BioCardia, Inc. (BCDA) stock
BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.77−0.02 (-2.06%)
Close on Nov 18, 2026Market cap $11.69MP/E –Yield –
BioCardia shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
BioCardia's shares outstanding was 12M at Jun 30, 2026. For fiscal 2025 it was 7M, up 143.0% from the year before. Over ten years it grew 44.0% a year on average. The highest annual figure on record is 18M in fiscal 2022.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7M | +143.0% |
| FY2024 | Dec 31, 2024 | 3M | +94.3% |
| FY2023 | Dec 31, 2023 | 1M | -92.0% |
| FY2022 | Dec 31, 2022 | 18M | +4.7% |
| FY2021 | Dec 31, 2021 | 17M | +67.2% |
| FY2020 | Dec 31, 2020 | 10M | +79.3% |
| FY2019 | Dec 31, 2019 | 6M | +32.4% |
| FY2018 | Dec 31, 2018 | 4M | +0.6% |
| FY2017 | Dec 31, 2017 | 4M | +356.0% |
| FY2016 | Dec 31, 2016 | 1M | +436.3% |
| FY2015 | Dec 31, 2015 | 0M | -91.6% |
| FY2014 | Dec 31, 2014 | 2M | 0.0% |
| FY2013 | Dec 31, 2013 | 2M | 0.0% |
| FY2012 | Dec 31, 2012 | 2M | 0.0% |
| FY2011 | Dec 31, 2011 | 2M | 0.0% |
| FY2010 | Dec 31, 2010 | 2M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 12M | +139.0% |
| Q1 FY2026 | Mar 31, 2026 | 11M | +133.2% |
| Q4 FY2025 | Dec 31, 2025 | 11M | +132.7% |
| Q3 FY2025 | Sep 30, 2025 | 6M | +122.0% |
| Q2 FY2025 | Jun 30, 2025 | 5M | +169.6% |
| Q1 FY2025 | Mar 31, 2025 | 5M | +176.7% |
| Q4 FY2024 | Dec 31, 2024 | 5M | +205.5% |
| Q3 FY2024 | Sep 30, 2024 | 3M | +96.2% |
| Q2 FY2024 | Jun 30, 2024 | 2M | +38.1% |
| Q1 FY2024 | Mar 31, 2024 | 2M | -91.7% |
| Q4 FY2023 | Dec 31, 2023 | 2M | -91.8% |
| Q3 FY2023 | Sep 30, 2023 | 1M | -91.9% |
| Q2 FY2023 | Jun 30, 2023 | 1M | -92.3% |
| Q1 FY2023 | Mar 31, 2023 | 20M | +18.2% |
| Q4 FY2022 | Dec 31, 2022 | 18M | +7.3% |
| Q3 FY2022 | Sep 30, 2022 | 18M | +4.6% |
| Q2 FY2022 | Jun 30, 2022 | 18M | +3.5% |
| Q1 FY2022 | Mar 31, 2022 | 17M | +3.0% |
| Q4 FY2021 | Dec 31, 2021 | 17M | +28.4% |
| Q3 FY2021 | Sep 30, 2021 | 17M | +35.2% |
| Q2 FY2021 | Jun 30, 2021 | 17M | +121.1% |
| Q1 FY2021 | Mar 31, 2021 | 17M | +142.5% |
| Q4 FY2020 | Dec 31, 2020 | 13M | +95.9% |
| Q3 FY2020 | Sep 30, 2020 | 13M | +109.2% |
| Q2 FY2020 | Jun 30, 2020 | 8M | +59.1% |
| Q1 FY2020 | Mar 31, 2020 | 7M | +60.8% |
| Q4 FY2019 | Dec 31, 2019 | 7M | +57.7% |
| Q3 FY2019 | Sep 30, 2019 | 6M | +41.8% |
| Q2 FY2019 | Jun 30, 2019 | 5M | +14.1% |
| Q1 FY2019 | Mar 31, 2019 | 4M | -0.0% |
| Q4 FY2018 | Dec 31, 2018 | 4M | +1.4% |
| Q3 FY2018 | Sep 30, 2018 | 4M | +0.3% |
| Q2 FY2018 | Jun 30, 2018 | 4M | +0.3% |
| Q1 FY2018 | Mar 31, 2018 | 4M | +0.3% |
| Q4 FY2017 | Dec 31, 2017 | 4M | +2319.0% |
| Q3 FY2017 | Sep 30, 2017 | 4M | – |
| Q2 FY2017 | Jun 30, 2017 | 4M | – |
| Q1 FY2017 | Mar 31, 2017 | 4M | – |
| Q3 FY2016 | Sep 30, 2016 | 0M | – |
See a number that looks wrong?